Oric Pharmaceuticals, Inc. ORIC Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s total current liabilities?
- Oric Pharmaceuticals, Inc. (ORIC) reported total current liabilities of $17.77M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Oric Pharmaceuticals, Inc.'s total current liabilities increased by 0.9% year-over-year, from $17.62M to $17.77M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s total current liabilities has grown at a 17.8% compound annual growth rate (CAGR), from $9M to $20.42M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.